Oscar Bladh

Publications
Public outreach and news

Articles

Article: FRONTIERS IN IMMUNOLOGY. 2024;15:1346749
Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum
Bladh O; Aguilera K; Marking U; Kihlgren M; Norin NG; Smed-Sorensen A; Chen MS; Klingstrom J; Blom K; Russell MW; Havervall S; Thalin C; Aberg M
Article: THE LANCET REGIONAL HEALTH. EUROPE. 2023;30:100646
Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational study.
Vikström L; Fjällström P; Gwon Y-D; Sheward DJ; Wigren-Byström J; Evander M; Bladh O; Widerström M; Molnar C; Rasmussen G; Bennet L; Åberg M; Björk J; Tevell S; Thålin C; Blom K; Klingström J; Murrell B; Ahlm C; Normark J; Johansson AF; Forsell MNE
Article: NATURE COMMUNICATIONS. 2023;14(1):1577
Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers
Marking U; Havervall S; Norin NG; Bladh O; Christ W; Gordon M; Ng H; Blom K; Phillipson M; Mangsbo S; Alm JJ; Smed-Sorensen A; Nilsson P; Hober S; Aberg M; Klingstroem J; Thalin C
Article: PLOS ONE. 2023;18(9):e0292132
Safety and tolerability of frozen, capsulized autologous faecal microbiota transplantation. A randomized double blinded phase I clinical trial
Stefansson M; Bladh O; Flink O; Skolling O; Ekre H-P; Rombo L; Engstrand L; Ursing J

All other publications

Letter: THE LANCET REGIONAL HEALTH. EUROPE. 2024;38:100872
Prevalence of SARS-CoV-2 infections among Swedish healthcare workers on duty in December 2023
Aguilera K; Bladh O; Marking U; Norin NG; Rihani A; Ujvari D; Ning FC; Klingstroem J; Havervall S; Aberg M; Blom K; Alm JJ; Thalin C
Letter: THE LANCET INFECTIOUS DISEASES. 2024;24(2):e80-e81
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden
Preprint: BIORXIV. 2023
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster
Marking U; Bladh O; Aguilera K; Yang Y; Norin NG; Blom K; Hober S; Klingström J; Havervall S; Åberg M; Sheward D; Thålin C
Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2023;389(17):1626-1628
Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection
Bladh O; Greilert-Norin N; Havervall S; Marking U; Aguilera K; Alm JJ; Blom K; Aberg M; Klingstrom J; Thalin C
Letter: THE LANCET REGIONAL HEALTH. EUROPE. 2023;33:100725
Point prevalence of SARS-CoV-2 infection among healthcare workers in March and June 2023 in Sweden
Blom K; Bladh O; Havervall S; Marking U; Norin NG; Alm JJ; Klingstrom J; Thalin C
Letter: THE LANCET INFECTIOUS DISEASES. 2023;23(8):e272-e273
Mucosal IgA protects against BQ.1 and BQ.1.1 infection
Marking U; Bladh O; Havervall S; Greilert-Norin N; Gordon M; Alm JJ; Blom K; Aberg M; Klingstrom J; Thalin C
Letter: THE LANCET MICROBE. 2023;4(7):e488
Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
Bladh O; Marking U; Havervall S; Norin NG; Aguilera K; Hober S; Smed-Soerensen A; Gordon M; Blom K; Aberg M; Klingstrom J; Thalin C
Preprint: MEDRXIV. 2023
Vaccine-induced correlate of protection against fatal COVID-19 in the old and frail during waves of neutralization resistant variants of concern
Vikström L; Fjällström P; Gwon Y-D; Sheward D; Wigren-Byström J; Evander M; Bladh O; Widerström M; Molnar C; Rasmussen G; Bennet L; Åberg M; Björk J; Tevell S; Thålin C; Blom K; Klingström J; Murrell B; Ahlm C; Normark J; Johansson A; Forsell MNE
Letter: THE LANCET INFECTIOUS DISEASES. 2023;23(2):150-152
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection
Marking U; Bladh O; Havervall S; Svensson J; Greilert-Norin N; Aguilera K; Kihlgren M; Salomonsson A-C; Mansson M; Gallini R; Kriegholm C; Bacchus P; Hober S; Gordon M; Blom K; Smed-Sorensen A; Aberg M; Klingstrom J; Thalin C
Preprint: MEDRXIV. 2022
Correlates of protection, viral load trajectories and symptoms in BA.1, BA.1.1 and BA.2 breakthrough infections in triple vaccinated healthcare workers
Marking U; Havervall S; Greilert Norin N; Bladh O; Christ W; Gordon M; Ng H; Blom K; Phillipson M; Mangsbo S; Smed Sörensen A; Nilsson P; Hober S; Åberg M; Klingström J; Thålin C
Preprint: BIORXIV.
Neutralisation sensitivity of the SARS-CoV-2 BA.2.87.1 variant
Sheward DJ; Marking U; Bladh O; Held S; Looyens E; Vandenabeele L; Muschiol S; Aguilera K; Norin NG; Öling S; Westerberg M; Martin D; Hedestam GBK; Albert J; Thålin C; Murrell B

Articles

All other publications

News from KI

Events from KI